CoChat

Retinal microglia initiate neuroinflammation in ocular autoimmunity

Open access
Okunuki, Yoko, Mukai, Ryo, Nakao, Takeshi, Tabor, Steven J., Butovsky, Oleg, Dana, Reza, Ksander, Bruce R., Connor, Kip M. · 2019 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Significance: Autoimmune uveitis is a serious sight-threatening condition defined by an autoreactive immune response against uveal tissues and the retina. As a result, patients with uveitis often suffer serious visual loss after persistent inflammation due to immune-mediated damage in the targeted tissues. Microglia are resident immune cells in the retina, and are thought to be the key population that initiates retinal inflammation; however, the exact role for microglia in autoimmune uveitis is still unknown. Here, we demonstrate that microglia are essential for the induction of a retinal autoimmune response, as microglial ablation completely blocks disease. Our data suggest that microglia mediate autoreactive immune cell entry into the retina, and that by depleting microglia, circulating immune cells cannot gain entry into the retina.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1820387116

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Microglia depletion suppresses EAU. C57BL/6 mice were fed PLX5622 (PLX), a Csf1r antagonist, or control diet starting 7 d before IRBP immunization (day 0). (A) Retinas were whole-mounted and stained for P2ry12 in naive mice and mice fed PLX for 3 and 7 d. Z-stack orthogonal view images of the entire thickness (including the inner and the outer plexiform layers and the ganglion cell layer) of the midperipheral retina were taken by confocal microscopy. Representative images from three to four retinas per time point are shown. (Scale bars: 100 μm.) (B) Time course of EAU clinical scores (n = 7 mice per group) by fundus observation. Scores were graded in a blinded manner on a scale between 0 and 4 in half-point increments as described previously. Briefly, trace chorioretinal lesions and minimal vasculitis were scored as 0.5. Mild vasculitis with small focal chorioretinal lesions (≤5) were scored as 1. Severe vasculitis with multiple chorioretinal lesions (>5) were scored as 2. A pattern of a linear chorioretinal lesion, subretinal neovascularization, and hemorrhage were scored as 3. Inflammation with large retinal detachment and severe hemorrhages were scored as 4. (C) Representative retinal fundus images indicating a score of 1.5 in control immunized mice (vasculitis and chorioretinal lesions) but absent in PLX-treated mice on day 21. (D) Histopathological EAU score on day 21 (n = 5 mice per group) were graded in a blinded manner on a scale between 0 and 4 in half-point increments as described previously. Briefly, focal nongranulomatous, monocytic infiltration in the choroid, ciliary body, and retina were scored as 0.5. Retinal perivascular infiltration and monocytic infiltration in the vitreous were scored as 1. Granuloma formation in the uvea and retina together with the presence of occluded retinal vasculitis, photoreceptor folds, serous retinal detachment, and loss of photoreceptors, were scored as 2. In addition, the formation of granulomas at the level of the retinal pigment epithelium and the development of subretinal neovascularization were scored as 3 and 4 according to the number and the size of the lesions. (E) Representative histopathological (H&E staining) images indicating a score of 1.5 (photoreceptor folds, vitreous cells, and retinal granulomas) in control mice and 0 (no inflammation) in PLX-treated mice. The average of scores from both eyes was determined as the score of the animal. (Scale bars: 100 μm.) (B and D) Mann–Whitney U test. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
Fig. 1. Microglia depletion suppresses EAU. C57BL/6 mice were fed PLX5622 (PLX), a Csf1r antagonist, or control diet starting 7 d before IRBP immunization (day 0). (A) Retinas were whole-mounted and stained for P2ry12 in naive mice and mice fed PLX for 3 and 7 d. Z-stack orthogonal view images of the entire thickness (including the inner and the outer plexiform layers and the ganglion cell layer) of the midperipheral retina were taken by confocal microscopy. Representative images from three to four retinas per time point are shown. (Scale bars: 100 μm.) (B) Time course of EAU clinical scores (n = 7 mice per group) by fundus observation. Scores were graded in a blinded manner on a scale between 0 and 4 in half-point increments as described previously. Briefly, trace chorioretinal lesions and minimal vasculitis were scored as 0.5. Mild vasculitis with small focal chorioretinal lesions (≤5) were scored as 1. Severe vasculitis with multiple chorioretinal lesions (>5) were scored as 2. A pattern of a linear chorioretinal lesion, subretinal neovascularization, and hemorrhage were scored as 3. Inflammation with large retinal detachment and severe hemorrhages were scored as 4. (C) Representative retinal fundus images indicating a score of 1.5 in control immunized mice (vasculitis and chorioretinal lesions) but absent in PLX-treated mice on day 21. (D) Histopathological EAU score on day 21 (n = 5 mice per group) were graded in a blinded manner on a scale between 0 and 4 in half-point increments as described previously. Briefly, focal nongranulomatous, monocytic infiltration in the choroid, ciliary body, and retina were scored as 0.5. Retinal perivascular infiltration and monocytic infiltration in the vitreous were scored as 1. Granuloma formation in the uvea and retina together with the presence of occluded retinal vasculitis, photoreceptor folds, serous retinal detachment, and loss of photoreceptors, were scored as 2. In addition, the formation of granulomas at the level of the retinal pigment epithelium and the development of subretinal neovascularization were scored as 3 and 4 according to the number and the size of the lesions. (E) Representative histopathological (H&E staining) images indicating a score of 1.5 (photoreceptor folds, vitreous cells, and retinal granulomas) in control mice and 0 (no inflammation) in PLX-treated mice. The average of scores from both eyes was determined as the score of the animal. (Scale bars: 100 μm.) (B and D) Mann–Whitney U test. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001.CC BY-NC-ND · PubMed Central
Fig. 2. Microglia depletion by a Csf1r antagonist in EAU does not alter the systemic immune response to the immunized peptide. C57BL/6 mice were fed the Csf1r antagonist PLX5622 (PLX) or a control diet 7 d before IRBP immunization, and animals were immunized on day 0. (A–E) Animals were evaluated for a systemic immune response against the IRBP-p. (A) Delayed hypersensitivity, as determined by ear swelling, was evaluated on day 21. Mice were injected intradermally with IRBP-p into the pinna of one ear on day 19. Ear swelling was measured after 48 h using a micrometer (n = 6–7 mice per group). (B–E) Cell proliferation was evaluated by using the cells isolated from LNs and spleens (SPs) on days 14 and 21. The cells were cultured in triplicate for 3 d in the presence of IRBP-p (10 μg), Con A (1 μg), or medium only (n = 5 mice per group). During the last 4 h before the 72-h end-point culture, the Cell Counting Kit-8 was added to each well. At 72 h, viable cell numbers in each well were measured as the absorbance (450 nm) of reduced WST-8. (F and G) Weights of the draining LNs (n = 5 mice per group) and SPs (n = 5 mice per group) were measured on day 21. Data were analyzed by one-way ANOVA, followed by Tukey’s multiple comparison test. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. n.s., not significant.
Fig. 2. Microglia depletion by a Csf1r antagonist in EAU does not alter the systemic immune response to the immunized peptide. C57BL/6 mice were fed the Csf1r antagonist PLX5622 (PLX) or a control diet 7 d before IRBP immunization, and animals were immunized on day 0. (A–E) Animals were evaluated for a systemic immune response against the IRBP-p. (A) Delayed hypersensitivity, as determined by ear swelling, was evaluated on day 21. Mice were injected intradermally with IRBP-p into the pinna of one ear on day 19. Ear swelling was measured after 48 h using a micrometer (n = 6–7 mice per group). (B–E) Cell proliferation was evaluated by using the cells isolated from LNs and spleens (SPs) on days 14 and 21. The cells were cultured in triplicate for 3 d in the presence of IRBP-p (10 μg), Con A (1 μg), or medium only (n = 5 mice per group). During the last 4 h before the 72-h end-point culture, the Cell Counting Kit-8 was added to each well. At 72 h, viable cell numbers in each well were measured as the absorbance (450 nm) of reduced WST-8. (F and G) Weights of the draining LNs (n = 5 mice per group) and SPs (n = 5 mice per group) were measured on day 21. Data were analyzed by one-way ANOVA, followed by Tukey’s multiple comparison test. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. n.s., not significant.CC BY-NC-ND · PubMed Central
Fig. 3. Csf1r antagonism does not suppress cytokine production in cells from LNs and spleens (SPs) in EAU, but suppresses CD11c+CD11b+ dendritic cells. C57BL/6 mice fed the PLX5622 (PLX) or control diet were immunized with IRBP-p. LN cells and SP cells from immunized mice on day 14 (PLX and control) and naive mice were analyzed by flow cytometry. CD11b and CD11c expression on CD45+ cells (A and D), IFN-γ and IL-17 expression on CD3+CD4+ cells (B and E), and CD25+Foxp3+ cells on CD3+CD4+ cells (C and F) in LNs (A–C) and in SPs (D–F) are shown (n = 5 mice per group). Data were analyzed using one-way ANOVA, followed by Tukey’s multiple comparison test. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. DCs, dendritic cells; MΦ, macrophage; n.s., not significant.
Fig. 3. Csf1r antagonism does not suppress cytokine production in cells from LNs and spleens (SPs) in EAU, but suppresses CD11c+CD11b+ dendritic cells. C57BL/6 mice fed the PLX5622 (PLX) or control diet were immunized with IRBP-p. LN cells and SP cells from immunized mice on day 14 (PLX and control) and naive mice were analyzed by flow cytometry. CD11b and CD11c expression on CD45+ cells (A and D), IFN-γ and IL-17 expression on CD3+CD4+ cells (B and E), and CD25+Foxp3+ cells on CD3+CD4+ cells (C and F) in LNs (A–C) and in SPs (D–F) are shown (n = 5 mice per group). Data were analyzed using one-way ANOVA, followed by Tukey’s multiple comparison test. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. DCs, dendritic cells; MΦ, macrophage; n.s., not significant.CC BY-NC-ND · PubMed Central
Fig. 4. Csf1r antagonism suppresses EAU in recipient mice but does not significantly suppress uveitogenicity of donor lymphocytes in adoptive transfer EAU models. Adoptive transfer EAU was induced in recipient mice by transferring activated lymphocytes from donor mice. The donor mice were immunized with IRBP-p, and spleens (SPs) and LNs were harvested 14 d postimmunization. The SP and LN cells isolated from donor mice were cultured for 3 d under stimulation with IRBP-p and IL-23. Adoptive transfer EAU was induced in recipient mice by i.p. transferring activated lymphocytes from donor mice. (A–C) PLX5622 (PLX) or control diet was given to recipient mice 7 d before cell transfer from donor mice. (A) Schematic time course of the experiment in which PLX was administered to recipient mice. (B) Time course clinical score (evaluated as in Fig. 1) and representative fundus images on day 13 (n = 5 mice per group). (C) Histopathological score on day 13 (evaluated as in Fig. 1) and representative images of the recipient PLX experiment (n = 5 mice per group). (D and E) PLX or control diet was given to donor mice 7 d before IRBP immunization, and cells were then i.p. transferred to recipient mice treated with a regular diet. (D) Schematic time course of the experiment in which PLX was given to donor mice. (E) Time course of clinical score and representative fundus images on day 14 in the donor PLX experiment (n = 5 mice per group). Mann–Whitney U test. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01. (Scale bars: 200 μm.)
Fig. 4. Csf1r antagonism suppresses EAU in recipient mice but does not significantly suppress uveitogenicity of donor lymphocytes in adoptive transfer EAU models. Adoptive transfer EAU was induced in recipient mice by transferring activated lymphocytes from donor mice. The donor mice were immunized with IRBP-p, and spleens (SPs) and LNs were harvested 14 d postimmunization. The SP and LN cells isolated from donor mice were cultured for 3 d under stimulation with IRBP-p and IL-23. Adoptive transfer EAU was induced in recipient mice by i.p. transferring activated lymphocytes from donor mice. (A–C) PLX5622 (PLX) or control diet was given to recipient mice 7 d before cell transfer from donor mice. (A) Schematic time course of the experiment in which PLX was administered to recipient mice. (B) Time course clinical score (evaluated as in Fig. 1) and representative fundus images on day 13 (n = 5 mice per group). (C) Histopathological score on day 13 (evaluated as in Fig. 1) and representative images of the recipient PLX experiment (n = 5 mice per group). (D and E) PLX or control diet was given to donor mice 7 d before IRBP immunization, and cells were then i.p. transferred to recipient mice treated with a regular diet. (D) Schematic time course of the experiment in which PLX was given to donor mice. (E) Time course of clinical score and representative fundus images on day 14 in the donor PLX experiment (n = 5 mice per group). Mann–Whitney U test. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01. (Scale bars: 200 μm.)CC BY-NC-ND · PubMed Central
Fig. 5. Microglial depletion following IRBP immunization diminishes EAU suppression. C57BL/6 mice were immunized with IRBP, and microglia depletion by PLX5622 (PLX) was started at different time points (days 0, 7, and 14 postimmunization) so that microglia depletion started at different time points of development of EAU. The animals fed the control diet without microglia depletion served as controls. Ocular inflammation was observed every 7 d until day 28. (A, Top) Diagram illustrates a normal time course of EAU in C57BL/6 mice. (A, Bottom) Three diagrams illustrate the timing of PLX administration (days 0, 7, and 14 postimmunization) and corresponding time courses of microglial depletion. (B–D) Time course of EAU clinical inflammation (days 7, 14, 21, and 28) (evaluated as in Fig. 1) and representative fundus images on day 21. PLX or the control diet was started on day 0 (B), day 7 (C), and day 14 (D) after immunization [mice per group: n = 7–8 (B), n = 7 (C), n = 8–9 (D)]. Mann–Whitney U test. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001. n.s., not significant.
Fig. 5. Microglial depletion following IRBP immunization diminishes EAU suppression. C57BL/6 mice were immunized with IRBP, and microglia depletion by PLX5622 (PLX) was started at different time points (days 0, 7, and 14 postimmunization) so that microglia depletion started at different time points of development of EAU. The animals fed the control diet without microglia depletion served as controls. Ocular inflammation was observed every 7 d until day 28. (A, Top) Diagram illustrates a normal time course of EAU in C57BL/6 mice. (A, Bottom) Three diagrams illustrate the timing of PLX administration (days 0, 7, and 14 postimmunization) and corresponding time courses of microglial depletion. (B–D) Time course of EAU clinical inflammation (days 7, 14, 21, and 28) (evaluated as in Fig. 1) and representative fundus images on day 21. PLX or the control diet was started on day 0 (B), day 7 (C), and day 14 (D) after immunization [mice per group: n = 7–8 (B), n = 7 (C), n = 8–9 (D)]. Mann–Whitney U test. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001. n.s., not significant.CC BY-NC-ND · PubMed Central
Fig. 6. Microglia interact with retinal vessels during development of EAU. EAU was induced in C57BL/6 mice, and whole-mount retinas were then stained with anti-P2ry12 antibody (magenta) and lectin (yellow) at 0, 7, 10, and 14 d after EAU induction. Confocal z-stack images of the entire retinal thickness in the midperipheral retina were taken and 3D-reconstructed using Amira software. (A) Representative images from a single scan area at each time point are shown: the top view of microglia (Left), the top view of microglia and lectin (Center), the bottom view (Top Right), and the side view (Bottom Right). The bottom view illustrates changes occurring under the retinal vascular bed (i.e., the outer nuclear layer and the photoreceptors), which are highlighted by masking the upper retina with an inserted black surface. (B) Magnified images of microglia from the areas surrounded by white squares in the images of day 0 and day 14 in A. At least four eyes were examined for each time point. (Scale bars: 50 μm.)
Fig. 6. Microglia interact with retinal vessels during development of EAU. EAU was induced in C57BL/6 mice, and whole-mount retinas were then stained with anti-P2ry12 antibody (magenta) and lectin (yellow) at 0, 7, 10, and 14 d after EAU induction. Confocal z-stack images of the entire retinal thickness in the midperipheral retina were taken and 3D-reconstructed using Amira software. (A) Representative images from a single scan area at each time point are shown: the top view of microglia (Left), the top view of microglia and lectin (Center), the bottom view (Top Right), and the side view (Bottom Right). The bottom view illustrates changes occurring under the retinal vascular bed (i.e., the outer nuclear layer and the photoreceptors), which are highlighted by masking the upper retina with an inserted black surface. (B) Magnified images of microglia from the areas surrounded by white squares in the images of day 0 and day 14 in A. At least four eyes were examined for each time point. (Scale bars: 50 μm.)CC BY-NC-ND · PubMed Central
Fig. 7. Microglia interact with adherent leukocytes in the retinal vessels during the development of EAU. (A and B) EAU was induced in mice with or without microglia depletion by PLX5622 (PLX). On day 10, retinal adherent leukocytes were imaged by perfusion labeling with FITC Con A lectin. (A) Representative images of flat-mounted retinas from each group are presented. Images are shown around the optic disk (Top) and the midperiphery (Bottom). Adherent leukocytes are indicated by arrows. (B) Mean number of adherent retinal leukocytes in major vessels per eye. (n = 6–8 retinas per group). Data were analyzed by one-way ANOVA, followed by Tukey’s multiple comparison test, and are expressed as mean ± SEM. **P < 0.01. n.s., not significant. (C–E) EAU was induced in C57BL/6 mice, and retinas were collected on day 10. Whole-mount immunohistochemistry was performed using antibodies against MHC class II (C), CD11b (D), or CD4/CD8 (E) (all green), with P2ry12 (red) and lectin (blue) staining. Stained retinas were observed using confocal microscopy. Images of microglia that appeared to interact with adherent leukocytes were taken by confocal microscopy, and z-stack images were created using ImageJ (NIH). Representative images were obtained by observation of at least three retinas per group. (Scale bars: A, 50 μm; C–E, 20 μm.)
Fig. 7. Microglia interact with adherent leukocytes in the retinal vessels during the development of EAU. (A and B) EAU was induced in mice with or without microglia depletion by PLX5622 (PLX). On day 10, retinal adherent leukocytes were imaged by perfusion labeling with FITC Con A lectin. (A) Representative images of flat-mounted retinas from each group are presented. Images are shown around the optic disk (Top) and the midperiphery (Bottom). Adherent leukocytes are indicated by arrows. (B) Mean number of adherent retinal leukocytes in major vessels per eye. (n = 6–8 retinas per group). Data were analyzed by one-way ANOVA, followed by Tukey’s multiple comparison test, and are expressed as mean ± SEM. **P < 0.01. n.s., not significant. (C–E) EAU was induced in C57BL/6 mice, and retinas were collected on day 10. Whole-mount immunohistochemistry was performed using antibodies against MHC class II (C), CD11b (D), or CD4/CD8 (E) (all green), with P2ry12 (red) and lectin (blue) staining. Stained retinas were observed using confocal microscopy. Images of microglia that appeared to interact with adherent leukocytes were taken by confocal microscopy, and z-stack images were created using ImageJ (NIH). Representative images were obtained by observation of at least three retinas per group. (Scale bars: A, 50 μm; C–E, 20 μm.)CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 225

Metadata

Authors
Okunuki, Y., Mukai, R., Nakao, T., Tabor, S. J., Butovsky, O., Dana, R., Ksander, B. R., & Connor, K. M.
Affiliations
  • Massachusetts Eye and Ear Infirmary (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Connor, Kip M.
Venue
Proceedings of the National Academy of Sciences
Published
2019-04-25
Volume
116
Issue
20
Pages
9989-9998
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2940580175
Cited by
216
References
67
Citations by year
2026: 24 · 2025: 42 · 2024: 45 · 2023: 27 · 2022: 39 · 2021: 22 · 2020: 12 · 2019: 3
FWCI
18.65
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • HHS | NIH | National Eye Institute (R01EY027303)
  • Massachusetts Lions Eye Research Fund (not applicable)
Topics
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
Keywords
retinal microglia, neuroinflammation, autoimmune uveitis, experimental autoimmune uveoretinitis, P2Y12 receptor, blood-retinal barrier, leukocyte infiltration, retinal inflammation, mouse model
MeSH terms
Animals, Autoimmune Diseases, Disease Models, Animal, Female, Organic Chemicals, Retinal Diseases, Uveitis, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Microglia, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retinal microglia initiate neuroinflammation in ocular autoimmunity. https://app.cochat.ai/papers/10.1073/pnas.1820387116
The paper
Okunuki, Y., Mukai, R., Nakao, T., Tabor, S. J., Butovsky, O., Dana, R., Ksander, B. R., & Connor, K. M. (2019). Retinal microglia initiate neuroinflammation in ocular autoimmunity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1820387116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.